title: Licence to save: a UK survey of anti-VEGF use for the eye in 2015.
authors: Department of Ophthalmology, University Hospital Southampton, Southampton, UK.
authors: A K
authors: AK
authors: Shalaby
authors: Department of Ophthalmology, University Hospital Southampton, Southampton, UK.
authors: K
authors: K
authors: Lewis
authors: Department of Ophthalmology, University Hospital Southampton, Southampton, UK.
authors: K
authors: K
authors: Bush
authors: Department of Ophthalmology, University Hospital Southampton, Southampton, UK.|Department of Ophthalmology, Queen Alexandra Hospital, Portsmouth, UK.
authors: P R
authors: PR
authors: Meredith
authors: Department of Ophthalmology, University Hospital Southampton, Southampton, UK.
authors: S
authors: S
authors: Di Simplicio
authors: Department of Ophthalmology, University Hospital Southampton, Southampton, UK.|Department of Ophthalmology, Queen Alexandra Hospital, Portsmouth, UK.|Moorfields Eye Hospital, London, UK.
authors: A J
authors: AJ
authors: Lockwood
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000191:economics*; D000068258:Bevacizumab / Q000008:administration & dosage / Q000191:economics; D017046:Cost Savings / Q000191:economics; D016527:Drug Costs / Q000331:legislation & jurisprudence*; D011307:Drug Prescriptions / Q000191:economics; D004363:Drug Utilization / Q000191:economics*; D006306:Health Surveys; D006801:Humans; D007880:Legislation, Drug / Q000191:economics*; D008268:Macular Degeneration / Q000188:drug therapy / Q000191:economics; D008269:Macular Edema / Q000188:drug therapy / Q000191:economics; D056687:Off-Label Use / Q000191:economics; D000069579:Ranibizumab / Q000008:administration & dosage / Q000191:economics; D040262:Receptors, Vascular Endothelial Growth Factor / Q000008:administration & dosage; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage / Q000191:economics; D013222:State Medicine / Q000191:economics; D006113:United Kingdom; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
chemical_list: D020533:Angiogenesis Inhibitors; D011993:Recombinant Fusion Proteins; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; C533178:aflibercept; D000068258:Bevacizumab; D040262:Receptors, Vascular Endothelial Growth Factor; D000069579:Ranibizumab